2019

1. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

   Therapeutic Advances in Gastroenterology, Vol. 12

2. Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU

   Alimentary Pharmacology and Therapeutics, Vol. 49, Núm. 4, pp. 419-428